US Patent Issued to DAEWOONG PHARMACEUTICAL on Dec. 16 for "Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,390, issued on Dec. 16, was assigned to DAEWOONG PHARMACEUTICAL Co. LTD. (Hwaseong-si, South Korea).

"Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same" was invented by Youn Jung Yoon (Yongin-si, South Korea) and Hee Kyoon Yoon (Cheongju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "An intermediate useful for the synthesis of an SGLT inhibitor and a method for preparing an SGLT inhibitor are provided. By employing an intermediate having Chemical Formula 5, the difficulty of purification with existing processes can be solved, the quality requirements for related substances can be a...